HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain
Cardio 2023

Nacole Riccaboni

Nacole Riccaboni, Speaker at Heart Conferences
Orlando Health Heart & Vascular Institute, United States
Title : Outpatient intravenous diuretic clinic use in heart failure


One million hospital admissions annually in the United States (US) are due to heart failure, with heart failure being the principal cause of 30-day readmissions. The major health problem with individuals diagnosed with heart failure is its high incidents of hospitalizations and readmissions. There is limited data available regarding the use of ambulatory intravenous diuretic clinics. Since heart failure-related hospitalizations are typically due to worsening congestion, loops diuretics are the mainstay of therapy in 90% of heart failure hospitalizations. Intravenous diuretic clinics thus an alternative for management of patients with heart failure. Hospitalization due to symptom presentation was thought to be imminent in more than one-half of patients referred to an intravenous diuretic clinic. With the use of intravenous diuretic clinic therapy, rates of 30- to 60- day hospitalizations were significantly lower after treatment.

Audience Take Away Notes

  • Implications of diuretic use
  • How intravenous diuretics differ from oral diuretics
  • Potential impact of outpatient intravenous diuretic clinic use


I am a heart failure nurse practitioner for Orlando Health Medical Group. I received my BSN from the Advent University of Health Sciences, then obtained my MSN from the University of South Alabama. I have an MBA from Capella University and am working on my doctorate degree at the University of Central Florida (in Executive Nursing Leadership). I have 10+ years of experience  of critical care.